| Np Healthcare Clinic | |
|
559a Highway 1 N Greenville MS 38701-3136 | |
| (662) 702-5159 | |
| (662) 702-5164 |
| Full Name | Np Healthcare Clinic |
|---|---|
| Speciality | Clinic/Center |
| Location | 559a Highway 1 N, Greenville, Mississippi |
| Authorized Official Name and Position | Alexis Cross (NURSE PRACTITIONER) |
| Authorized Official Contact | 6623793648 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Np Healthcare Clinic Po Box 5164 Greenville MS 38704-5164 Ph: (662) 379-3648 | Np Healthcare Clinic 559a Highway 1 N Greenville MS 38701-3136 Ph: (662) 702-5159 |
| NPI Number | 1063909539 |
|---|---|
| Provider Enumeration Date | 04/19/2018 |
| Last Update Date | 11/07/2018 |
| Medicare PECOS PAC ID | 2567710940 |
|---|---|
| Medicare Enrollment ID | O20180801000868 |
News Archive
A musician takes up his/her violin and starts to play, but rather than gripping the strings, the fingers seize up—and this happens every time he/she takes up the instrument. Such a movement disorder—the so-called focal dystonia— is a dramatic disease for those affected, which has thus far barely been studied.
The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications is pleased to announce that its collaboration with leading translational research group, the EPSRC Centre for Innovative Manufacturing in Regenerative Medicine at Loughborough University is to continue into a second five year phase. This follows the recent announcement by Prime Minister, Gordon Brown and Lord Mandelson, UK Secretary of State, Department for Business, Innovation and Skills of a £5.33 million grant to the centre.
In its session at the World Cancer Congress, DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association explained how fragmentation within healthcare systems makes it difficult for them to effectively manage complex conditions such as cancer where the various dimensions of care - prevention, screening, diagnosis, treatment and palliation – are inseparable.
The addition of Cetuximab (brand name Erbitux) to radiation therapy treatments does not increase the rate or duration of some side effects in the treatment of advanced head and neck cancers, according to a study presented at the plenary session today at the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063909539 | NPI | - | NPPES |
| 06233378 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| Provider Name | Alexis Cross-montgomery |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730552787 PECOS PAC ID: 8224334420 Enrollment ID: I20160315001177 |
News Archive
A musician takes up his/her violin and starts to play, but rather than gripping the strings, the fingers seize up—and this happens every time he/she takes up the instrument. Such a movement disorder—the so-called focal dystonia— is a dramatic disease for those affected, which has thus far barely been studied.
The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications is pleased to announce that its collaboration with leading translational research group, the EPSRC Centre for Innovative Manufacturing in Regenerative Medicine at Loughborough University is to continue into a second five year phase. This follows the recent announcement by Prime Minister, Gordon Brown and Lord Mandelson, UK Secretary of State, Department for Business, Innovation and Skills of a £5.33 million grant to the centre.
In its session at the World Cancer Congress, DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association explained how fragmentation within healthcare systems makes it difficult for them to effectively manage complex conditions such as cancer where the various dimensions of care - prevention, screening, diagnosis, treatment and palliation – are inseparable.
The addition of Cetuximab (brand name Erbitux) to radiation therapy treatments does not increase the rate or duration of some side effects in the treatment of advanced head and neck cancers, according to a study presented at the plenary session today at the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.
› Verified 9 days ago
| Provider Name | Yakitta Landrum-lovett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1740761956 PECOS PAC ID: 5991040073 Enrollment ID: I20181218001162 |
News Archive
A musician takes up his/her violin and starts to play, but rather than gripping the strings, the fingers seize up—and this happens every time he/she takes up the instrument. Such a movement disorder—the so-called focal dystonia— is a dramatic disease for those affected, which has thus far barely been studied.
The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications is pleased to announce that its collaboration with leading translational research group, the EPSRC Centre for Innovative Manufacturing in Regenerative Medicine at Loughborough University is to continue into a second five year phase. This follows the recent announcement by Prime Minister, Gordon Brown and Lord Mandelson, UK Secretary of State, Department for Business, Innovation and Skills of a £5.33 million grant to the centre.
In its session at the World Cancer Congress, DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association explained how fragmentation within healthcare systems makes it difficult for them to effectively manage complex conditions such as cancer where the various dimensions of care - prevention, screening, diagnosis, treatment and palliation – are inseparable.
The addition of Cetuximab (brand name Erbitux) to radiation therapy treatments does not increase the rate or duration of some side effects in the treatment of advanced head and neck cancers, according to a study presented at the plenary session today at the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.
› Verified 9 days ago
| Provider Name | Hadonica Murphy |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336709872 PECOS PAC ID: 7416285267 Enrollment ID: I20190819001359 |
News Archive
A musician takes up his/her violin and starts to play, but rather than gripping the strings, the fingers seize up—and this happens every time he/she takes up the instrument. Such a movement disorder—the so-called focal dystonia— is a dramatic disease for those affected, which has thus far barely been studied.
The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications is pleased to announce that its collaboration with leading translational research group, the EPSRC Centre for Innovative Manufacturing in Regenerative Medicine at Loughborough University is to continue into a second five year phase. This follows the recent announcement by Prime Minister, Gordon Brown and Lord Mandelson, UK Secretary of State, Department for Business, Innovation and Skills of a £5.33 million grant to the centre.
In its session at the World Cancer Congress, DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association explained how fragmentation within healthcare systems makes it difficult for them to effectively manage complex conditions such as cancer where the various dimensions of care - prevention, screening, diagnosis, treatment and palliation – are inseparable.
The addition of Cetuximab (brand name Erbitux) to radiation therapy treatments does not increase the rate or duration of some side effects in the treatment of advanced head and neck cancers, according to a study presented at the plenary session today at the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.
› Verified 9 days ago
News Archive
A musician takes up his/her violin and starts to play, but rather than gripping the strings, the fingers seize up—and this happens every time he/she takes up the instrument. Such a movement disorder—the so-called focal dystonia— is a dramatic disease for those affected, which has thus far barely been studied.
The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications is pleased to announce that its collaboration with leading translational research group, the EPSRC Centre for Innovative Manufacturing in Regenerative Medicine at Loughborough University is to continue into a second five year phase. This follows the recent announcement by Prime Minister, Gordon Brown and Lord Mandelson, UK Secretary of State, Department for Business, Innovation and Skills of a £5.33 million grant to the centre.
In its session at the World Cancer Congress, DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association explained how fragmentation within healthcare systems makes it difficult for them to effectively manage complex conditions such as cancer where the various dimensions of care - prevention, screening, diagnosis, treatment and palliation – are inseparable.
The addition of Cetuximab (brand name Erbitux) to radiation therapy treatments does not increase the rate or duration of some side effects in the treatment of advanced head and neck cancers, according to a study presented at the plenary session today at the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.
› Verified 9 days ago
The Greenville Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1502 S Colorado St, Greenville, MS 38703 Phone: 662-332-9872 Fax: 662-332-9878 | |
Magnolia Family Medical Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1660 S Colorado St, Greenville, MS 38703 Phone: 662-332-2077 Fax: 662-332-0790 | |
Infusions,llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1313 E Union St, Greenville, MS 38703 Phone: 662-332-1153 Fax: 662-332-1157 | |
Dominick Trinca, M.d. Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1440 Highway 1 S, Greenville, MS 38701 Phone: 662-820-4363 | |
Delta Health Provider Based Clinics Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1400 E Union St, Greenville, MS 38703 Phone: 662-378-3783 Fax: 662-725-2289 | |
F H Faith Medical Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1508 Hospital St, Greenville, MS 38703 Phone: 662-332-8848 Fax: 662-332-8854 |